Proteolysis-targeting chimera molecules targeting SHP2

D Yu, M Zheng, Y Liu, L Chen, H Li - Future Medicinal Chemistry, 2022 - Future Science
SHP2 is a member of the non-receptor protein tyrosine phosphatases, encoded by PTPN11,
and exhibits oncogenic activities. The close association between SHP2 and human cancer …

Strategies targeting protein tyrosine phosphatase SHP2 for cancer therapy

Y Song, S Wang, M Zhao, X Yang… - Journal of Medicinal …, 2022 - ACS Publications
The protein tyrosine phosphatase SHP2 encoded by PTPN11 is a promising therapeutic
target for cancer therapy, while the multifaceted roles of SHP2 complicate the drug discovery …

Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders

X Yang, Z Wang, Y Pei, N Song, L Xu, B Feng… - European Journal of …, 2021 - Elsevier
SHP2, a non-receptor tyrosine phosphatase, plays a pivotal role in numerous oncogenic cell-
signaling cascades like RAS-ERK, PI3K-AKT and JAK-STAT. On the other hand, proteolysis …

Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials

Y Song, M Zhao, H Zhang, B Yu - Pharmacology & therapeutics, 2022 - Elsevier
Phosphorylation is a reversible post-translational modification regulated by phosphorylase
and dephosphorylase to mediate important cellular events. Src homology-2-containing …

Targeting SHP2 for Cancer Treatment: Advances and Prospects

Y Song, B Yu - Handbook of Cancer and Immunology, 2023 - Springer
Src homology region 2-containing protein tyrosine phosphatase 2 (SHP2), encoded by the
PTPN11, is a non-receptor protein tyrosine phosphatase that expressed in cytoplasmic …

Discovery of SHP2-D26 as a first, potent, and effective PROTAC degrader of SHP2 protein

M Wang, J Lu, M Wang, CY Yang… - Journal of medicinal …, 2020 - ACS Publications
Src homology 2 domain-containing phosphatase 2 (SHP2) is an attractive therapeutic target
for human cancers and other human diseases. Herein, we report our discovery of potent …

Crystallographic landscape of SHP2 provides molecular insights for SHP2 targeted drug discovery

Y Song, X Yang, S Wang, M Zhao… - Medicinal Research …, 2022 - Wiley Online Library
The protein tyrosine phosphatase SHP2 encoded by PTPN11 is a promising therapeutic
target for cancer therapy. The dynamic change of SHP2 between closed and open …

Therapeutic potential of targeting SHP2 in human developmental disorders and cancers

D Shen, W Chen, J Zhu, G Wu, R Shen, M Xi… - European Journal of …, 2020 - Elsevier
Abstract Src homology 2 (SH2)-containing protein tyrosine phosphatase 2 (SHP2), encoded
by PTPN11, regulates cell proliferation, differentiation, apoptosis and survival via releasing …

[HTML][HTML] Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity

J Miao, Y Bai, Y Miao, Z Qu, J Dong, RY Zhang… - Molecules, 2023 - mdpi.com
Src homology 2 domain-containing phosphatase 2 (SHP2) is an attractive target for cancer
therapy due to its multifaceted roles in both tumor and immune cells. Herein, we designed …

Novel PROTACs for degradation of SHP2 protein

M Zheng, Y Liu, C Wu, K Yang, Q Wang, Y Zhou… - Bioorganic …, 2021 - Elsevier
Protein tyrosine phosphatase SHP2 is a member of PTPs family associated with cancer such
as leukemia, non-small cell lung cancer, breast cancer, and so on. SHP2 is a promising …